CDC25A and breast carcinoma: In conclusion, here we have shown that CPX induced Cdc25A degradation neither by increasing CK1α or decreasing DUB3 expression, nor via activating GSK3β in rhabdomyosarcoma (Rh30) and breast carcinoma (MDA-MB-231) cells.